We studied the expression of a molecularly cloned human c-src gene, c-src-1, localized on chromosome 20, whose coding region consists of 11 exons and spans a 19.5-kilobase (kb) distance. Using a replication-competent retroviral vector derived from molecularly cloned Rous sarcoma virus DNA (pSRA-2), we obtained two constructs: one (pSR-CS) carrying the unmodified human c-src coding sequence and another (pSR-CVS) with a chimeric gene formed between the human c-src gene and the carboxy-terminal 12-amino acid v-src-speciflc coding sequence. From chicken embryo fibroblasts transfected with these DNA constructs, infectious viruses designated as WO CS and WO CVS, respectively, were recovered. WO CS virus did not cause cell transformation, whereas WO CVS induced cell transformation. Analyses of the proviral DNAs indicated that all introns were spliced out such that the 19-kb inserts were converted to 1.7-kb cDNA forms. Analyses of src proteins in infected cells, using monoclonal antibody MAb327 against v-src protein, showed the following results. The CVS and CS src proteins were about 60 and 61 kilodaltons in size, respectively; the specific protein kinase activity assayed in vitro of the CVS src protein was about 20-fold higher than that of the CS src protein and comparable to that of the v-src protein; the transforming CVS src protein reacted to an antibody against a v-src-specific peptide, whereas the CS src protein did not. These results indicate that the human c-src gene has a potential transforming ability and suggest that the v-src-specific sequence played an important role in the generation of Rous sarcoma virus.
We studied the expression of a molecularly cloned human c-src gene, c-src-1, localized on chromosome 20, whose coding region consists of 11 exons and spans a 19.5-kilobase (kb) distance. Using a replication-competent retroviral vector derived from molecularly cloned Rous sarcoma virus DNA (pSRA-2), we obtained two constructs: one (pSR-CS) carrying the unmodified human c-src coding sequence and another (pSR-CVS) with a chimeric gene formed between the human c-src gene and the carboxy-terminal 12-amino acid v-src-speciflc coding sequence. From chicken embryo fibroblasts transfected with these DNA constructs, infectious viruses designated as WO CS and WO CVS, respectively, were recovered. WO CS virus did not cause cell transformation, whereas WO CVS induced cell transformation. Analyses of the proviral DNAs indicated that all introns were spliced out such that the 19-kb inserts were converted to 1.7-kb cDNA forms. Analyses of src proteins in infected cells, using monoclonal antibody MAb327 against v-src protein, showed the following results. The CVS and CS src proteins were about 60 and 61 kilodaltons in size, respectively; the specific protein kinase activity assayed in vitro of the CVS src protein was about 20-fold higher than that of the CS src protein and comparable to that of the v-src protein; the transforming CVS src protein reacted to an antibody against a v-src-specific peptide, whereas the CS src protein did not. These results indicate that the human c-src gene has a potential transforming ability and suggest that the v-src-specific sequence played an important role in the generation of Rous sarcoma virus.
Evidence has been accumulating, through studies on both retroviral oncogenes (v-onc) (3, 22) and their cellular counterparts (proto-oncogenes or c-onc) (3, 19, 55) , that c-onc genes are involved in cancer (31, 33) . Human c-onc genes have been vigorously studied since the demonstration of their involvement in human cancer (44, 56) . The c-onc genes of the myc group (31) , ras group (33) , abl (16) , and erbB (18) have been implicated in human cancer. However, there is no direct evidence indicating that the c-src gene is involved in human cancer or in cancers of other vertebrates, although there are some data suggesting its involvement in some human tumors (4, 28, 35, 46, 51) .
The v-src gene of Rous sarcoma virus (RSV), the retroviral oncogene first identified and most intensively studied, is believed to have been derived from its normal counterpart, the c-src oncogene, through processes involving recombination events and acquisition by a leukemia virus (36, 58, 60) . The v-src and c-src gene products are about 60 and 61 kilodaltons (kDa), respectively, in molecular size (7, 9) and possess tyrosine-specific protein kinase activities (8, 24, 40, 45) .
The c-src oncogene in humans has been molecularly cloned in its genomic form (20, 41) . The coding region consists of 11 exons (20) , as was seen also in the chicken c-src gene (58) . The human c-src coding region spans a distance of 19.5 kilobases (kb), more than three times that of the chicken c-src coding region (6 kb) (20, 58) . The amino acid sequence of the human c-src protein deduced from the DNA sequence showed that the amino acid homology of the region from exon 3 to 12 is 98% as compared to the corresponding chicken c-src region, whereas the aminoterminal region corresponding to exon 2 diverges significantly (71% amino acid homology) and possesses three * Corresponding author. additional amino acid residues (2; A. Tanaka et al., manuscript in preparation). Furthermore, the carboxy-terminal 19-amino acid sequence of the human c-src protein is identical to that of the chicken c-src-specific amino acid sequence but different from the carboxy-terminal 12-amino acid sequence of the v-src protein (the v-src-specific amino acid sequence) (2, 58) .
It has been reported that the overproduced chicken c-src protein does not induce cell transformation (23, 25, 27, 42, 50) . However, the chicken c-src protein expressed at extremely high levels in an established cell line induces weak cell transformation (14, 29) . It has also been reported that src proteins encoded by various chimeric molecules formed between the chicken c-src and v-src genes caused cell transformation (23, 25, 27, 50) . The role of the carboxyterminal 12-amino acid v-src-specific sequence, however, has remained unclear.
Using a replication-competent retroviral vector (23) derived from RSV DNA molecularly cloned into pBR322 (17), we examined whether the coding region of the human c-src gene localized on chromosome 20 was functional, whether the overexpressed human c-src protein induced cell transformation, and whether a chimeric human c-src gene in which only the region encoding the carboxy-terminal c-srcspecific 19 amino acids was replaced by the region coding for the carboxy-terminal v-src-specific 12 amino acids was capable of causing cell transformation. The construct pAT CS contains the entire coding region of the human c-src gene (c-src-l), which corresponds to the region between ATG shown by an arrow at an NcoI site (CCATGG) and a BamHI site (Ba*), which was abolished by ligation to a PvuII-BamHI fragment containing a 3'-end v-src sequence, one LTR (47) , and a part of the gag gene (see Fig. 2A ). (B) The construct pAT CVS is a chimeric molecule of the human c-srcand v-src-specific sequences. The human c-src region is between the ATG and a PstI site, which is located 99 bases upstream of the BamHI site (Ba*) (2; S. Anderson and D. J. Fujita, unpublished observation). Therefore, this clone lacks the PstI-BamHI (Ba*) c-src-specific region of pAT CS, which has been replaced with an RSV sequence (PstI-BamHI) containing the 3'-end v-src-specific sequence, two LTRs, and a part of the gag region (see Fig. 2A ). In both clones, a 0.2-kb intron sequence (SaII-XhoI) between exons 7 and 8 was deleted (A). Also, both clones lack the 0.4-kb BamHI-EcoRI sequences of pBR322, which were deleted upon insertion of LTR-containing sequences, resulting in abolishment of the EcoRI site of pBR322. (C) The construct pSR (23) Fig. 2A) . For pAT CVS, a 1.6-kb fragment (PstI-BamHI) of pSRA-2 which contains the v-src-specific sequence, two LTRs, and a part of the gag gene (17) was inserted between a PstI site within the insert and the EcoRI site of pB 0.6 ( Fig.  2A) Insertion of the middle region of human c-src sequence was done as follows. A 6.8-kb fragment (SalI-XhoI) containing part of the env gene and exons 2 and 3 was prepared from subconstruct pl and inserted between the SalI and XhoI sites of both pIlI CS and plll CVS (subconstructs pIV CS and pIV CVS). At this step, the 0.2-kb intron (SalI-XhoI) between exon 7 and exon 8 was deleted (A in Fig. 1 ). An 11-kb fragment (XhoI-SalI) containing exons 4, 5, 6, and 7 was inserted into the XhoI site of both pIV CS and pIV CVS. pAT CS and pAT CVS were obtained by the colony hybridization method (38) .
To obtain pSR-CS and pSR-CVS forms ( Fig. 1D ), each plasmid (pSR, pAT CS, and pAT CVS) was digested with Sail, and appropriate molar equivalent DNAs were ligated for 1 to 2 h up to the extent at which approximately 50% ligation of DNAs was achieved. These DNA samples were used for DNA transfection experiments.
Transfection. Transfection was done as described previously (17) by the calcium phosphate method (21) by using 3 to S ,ug of DNA for each sample, either with or without carrier DNAs. As a positive control, the RSV SRA-2 DNA fragment (1 ,ug per sample) purified from pSRA-2 was used. Usually, focal transforming areas were observed within 4 to 6 days after transfection with SRA-2 DNA.
Southern blotting analysis. Southern blotting analyses were done to examine either cloned DNAs or cellular DNAs as described previously (20, 38) . 32P-labeled DNA probes used were: the RSV SRA-2 DNA fragment purified from pSRA-2; a human c-src exon 5 DNA fragment (0.4 kb) prepared from an M13mp8 clone, containing the exon 5 region (104 bases) and an intron region, that was isolated by C. P. Gibbs (Rockefeller University) and H.-J. Kung (Fig. 1A) (2, 20, 41) . To test whether this locus is functional and whether the human c-src gene product is capable of transforming cells, we constructed an avian retroviral expression vector (23) , a modified form of RSV SRA-2 DNA molecularly cloned into pBR322 (a gift from J. M. Bishop) (17), with two types of inserts (Fig. 1) . One construct (pAT CS) contains the human c-src gene (ATG to Ba* in Fig. 1A) , in which the entire human c-src coding region remains intact except for a 0.2-kb intron region (SalI-XhoI) (A in Fig. 1A ) that had been removed to generate a unique Sall site. The second construct (pAT CVS) contains a chimeric molecule derived from the human c-src gene and the v-src sequence (Fig. 1B) . In the pAT CVS construct, the human c-src coding region is unchanged except for the region corresponding to the carboxy-terminal 19-amino acid c-src-specific sequence (2, 58) which was replaced with the region corresponding to the carboxy-terminal 12-amino acid v-src-specific sequence (36, 58) (Fig. 2A and B) .
These two constructs were each ligated to the pSR DNA (Fig. 1C) (23) after the plasmid DNAs were digested with SalI. Thus, two types of constructs (pSR-CS and pSR-CVS) were obtained as replication-competent DNA forms (Fig.   1D ) since they are exactly the same in structure as the DNA form of RSV except for the presence of extremely large introns.
Transfection of CEF with DNAs containing the pSR-CS or the pSR-CVS form. The DNAs containing the two types of constructs (pSR-CS and pSR-CVS) were used to transfect CEF by the calcium phosphate method (17, 21) . The viruses WO CS and WO CVS were obtained from culture media of pSR-CS-and, pSR-CVS-transfected cells, respectively, which had been cultured for about a month. These viruses are characterized below.
pSR-CVS transfectants showed morphological transformation at several focal areas of cultures on day 6 after transfection, and the cultures became fully transformed within several days of further incubation. The morphology of the pSR-CVS-transformed cells was very different from that of RSV SRA-2-transformed cells, which were also obtained by transfection with SRA-2 DNA (Fig. 3) .
In pSR-CS transfectants, however, we did not see any obvious morphological indication of cell transformation when cells were kept at the growing stage by routine passages over a 1-month period (Fig. 3) . However, when cells were maintained without passaging, we always observed several focal portions which showed morphological transformation. This is due to generation of transforming viruses spontaneously derived from WO CS-infected cultures (23, 25, 27; unpublished observation).
Thus, the pSR-CVS construct showed clear transforming ability. On the other hand, the vast majority of the pSR-CStransfected cultures were not morphologically transformed but appeared similar to uninfected cell cultures (Fig. 3) .
Analysis of proviral DNAs in transfectant cellular DNAs. To demonstrate that the pSR-CS and pSR-CVS transfectant cellular DNAs contained the human c-src sequences and to examine whether the integrated DNAs corresponded to spliced forms, i.e., cDNA forms, we performed a series of Southern blotting analyses. Human c-src sequences could be distinguished from either the v-src or chicken c-src sequences under stringent hybridization conditions with a probe derived from the human c-src exon 5 region, whose nucleotide sequence has a homology of 75% to the corresponding region of either the v-src or chicken c-src gene (C. P. Gibbs and H.-J. Kung, unpublished observation).
Cellular DNAs extracted from each transfectant after 1 month in culture were digested with EcoRI and subjected to Southern blotting analysis (Fig. 4) . All transfectant DNAs hybridized with the RSV SRA-2 probe showed a typical hybridization pattern, three fragments of 2.3 3.9, and 3.1 to 3.2 kb, characteristic of RSV proviral DNA (Fig. 4A) . In the case of the SRA-2 provirus, the 3.1-kb EcoRI fragment contains the v-src sequence (data not shown) (17) . When hybridized with the human c-src exon 5 probe under stringent conditions, fragments of 3.1 and 3.2 kb were detected in pSR-CVS and pSR-CS transfectant DNAs, respectively (Fig. 4B) . This indicates that the DNAs of these transfectants indeed contain the human c-src sequences. Furthermore, when the probe of a 3'-end c-src-specific region (PstI-BamHI [Ba*] region in Fig. 2 ) was used, only the pSR-CS sequence was detected, and there was no significant hybridization to the pSR-CVS (Fig. 4C) , indicating that the pSR-CS and pSR-CVS transfectant DNAs contain the expected sequences. In addition, we repeatedly noticed that the EcoRI fragment containing the c-src sequence (3.2 kb) of pSR-CS was slightly larger in size than the others (3.1 kb). This is because pAT CS is 100 bases larger than pAT CVS at the 3' end ( Fig. 2A) The shortest intron within the numan c-src genomic sequence is located between exons 10 and 11, and its size is about 160 bases (2, 20) . This could have been detected under these analytical conditions if it remained in the integrated DNAs. The 3.1-kb src-containing fragment of pSR-CVS is indistinguishable from that of pSRA-2 in size (Fig. 4A) . This strongly suggests that all introns present in the original construct were successfully spliced out through RNA splicing mechanisms, such that the 19-kb genomic human c-src (Fig. 1D ). This may be related to the observation that transfected RSV DNAs are capable of producing viruses without their integration into chromosomal DNA (10) .
Detection of human c-src-derived proteins. pSR-CS and pSR-CVS each has an LTR (47) at its 3' end which contains a strong promoter for mRNA synthesis (62) and which was derived from RSV SRA-2 DNA ( Fig. 1 and 2 ). Therefore we could expect that if CEF were infected with vituses harvested from the transfectant cultures, they would contain levels of src proteins comparable to that of RSV SRA-2-transformed cells. To examine this question, CEF fully infected with WO CS, WO CVS, or SRA-2 virus were labeled with either [35S]methionine or 32Pi and subjected to immunoprecipitation analyses with monoclonal antibody MAb327 (37) against the v-src protein (7) .
Levels of the CS and CVS src proteins in the infected cells were significantly higher than that of the endogenous chicken c-src protein ( Fig. SA ; also see Table 1) . However, the level of CS src protein was slightly lower than those of CVS src and SRA-2 v-src proteins. This may result from the presence of a significant amount of transformation-defective viruses having deletions within the src coding region (22) of CS src protein is about 61 kDa which is about 1 kDa larger than that of the CVS or v-src protein, but similar to that of the chicken endogenous c-src protein (9, 40, 45) . This difference is mainly due to the presence of seven additional amino acid residues at the carboxy-terminal of the CS src protein compared with the v-src or CVS src protein (Fig. 2B)  (2, 58) .
To examine whether the CVS src protein contains the expected v-src-specific amino acid sequence, we subjected [35S]methionine-labeled cells to immunoprecipitation with an antiserum against a carboxy-terminal v-src-specific peptide (49) . The CVS src protein as well as v-src protein was reactive to this antibody, but the CS src protein was not (Fig.   6 ), indicating that the CVS src protein is the expected chimeric src protein expressed from the pSR-CVS construct ( Fig. 1 and 2 ). This clearly indicates that the human c-src gene can be activated by some alterations resulting in a modification of the src protein.
The CS src protein does not induce cell transformation. As mentioned above, the majority of cells were not morphologically transformed upon infection with WO CS virus or transfection with the pSR-CS construct. To confirm that the CS src protein does not induce cell transformation, we performed the following series of experiments. CEF fully C-) 01) '4- Table 1 ).
The following results were obtained. (i) The focus-forming ability of the WO CS virus-containing media was more than 600-fold less than that of the WO CVS-or SRA-2 viruscontaining media, whereas RTase activities were comparable (Table 1) Table 1 were obtained from this experiment.
kinase was about 20-fold less than those of the CVS and SRA-2 src proteins and was similar to that of the endogenous chicken c-src protein (Table 1) . Furthermore, CEF infected with transforming viruses isolated from WO CS-infected cultures did not behave like the majority of CEF infected with WO CS virus but became transformed (data not shown). Therefore, we conclude that the CS src protein does not induce cell transformation under usual culture conditions.
DISCUSSION
In this work with the replication-competent RSV vector system, we demonstrated that the coding region of the human c-src gene (c-src-1) carried by the WO CS virus genome is functional and that the c-src gene product (CS src protein) does not induce cell tranformation under our assay conditions. We also demonstrated that the human c-src gene has a potential transforming ability since a modified human c-src gene is capable of inducing cell transformation as is the case with the WO CVS virus. Recent molecular cloning of cDNA forms of the CS and CVS genes derived from the viruses and subsequent DNA sequencing of the cloned DNAs further confirmed that the viruses obtained, WO CS and WO CVS, had the expected properties. The genomic forms of CS and CVS in the original constructs as well as the 3' v-src-specific region encoding the carboxy-terminal 12- amino acid residues for the CVS construct had been correctly inserted into the RSV vectors; and all 10 introns present in the original CS genomic construct had been correctly spliced out (unpublished observation).
Is the human c-src protein properly regulated in CEF? Although the amino acid sequence at the amino-terminal region of the human c-src protein is significantly different from that of the chicken c-src protein, the human CS src protein expressed in infected CEF appears to be very similar to the chicken c-src protein expressed at high levels in c-src virus-infected CEF (23, 25, 27) in terms of its molecular size, lack of transforming ability, and low activity of src protein kinase assayed in vitro relative to that of the v-src protein. Also, in both cases, the virus stocks recovered from the nontransforming c-src DNA-transfected cultures contained a minor amount of transforming viruses. Furthermore, the specific activity of the CS src protein kinase is similar to that of the endogenous chicken c-src protein. These observations suggest that the CS src protein expressed in CEF is properly regulated. The v-src-specific carboxy-terminal 12-amino acid sequence may have played an important role in the generation of RSV. The observed transforming activity of the src gene of WO CVS virus containing the carboxy-terminal 12-amino acid v-src-specific coding sequence (58) instead of the 19-amino acid c-src-specific coding sequence (2) clearly showed that the presence of the v-src-specific sequence within the src protein resulted in acquisition of cell-transforming ability.
It has been shown that a chimeric molecule formed between the chicken c-src and RSV v-src genes, in which a carboxy-terminal 94-amino acid sequence was derived from the v-src coding sequence, induced cell transformation (23, 27, 50) . However, in addition to the v-src-specific region, the 94-amino acid sequence contains three amino acid residues which are also different from the corresponding residues in the chicken c-src amino acid sequence. Our result suggests that the v-src-specific sequence alone probably imparted transforming ability to the chicken c-src protein and played an important role in the generation of RSV (36, 58) .
Presence of a regulatory domain at the carboxy-terminal region of the c-src protein. It has been proposed that the src protein consists of four domains, i.e., membrane-binding, target recognition, kinase (catalytic), and regulatory domains (43) . The regulatory domain has been placed at the region near the carboxy-terminal c-src-or v-src-specific sequence since mutation near or within the v-src-specific region resulted in both the loss of transforming ability and the decrease of the kinase activity of the v-src protein (43, 61) . The kinase domain of the src protein thus appears to be very sensitive to structural changes at the region near the v-src-specific sequence.
A related phenomenon was observed when the 19-amino acid c-src-specific coding sequence was replaced by the 12-amino acid v-src-specific coding sequence. In this case, however, the structural change resulted in an activated c-src gene, whose src protein induced cell transformation and possessed high in vitro kinase activity. Thus, it is very possible that conformational changes in or near the c-srcspecific sequence participate in the regulation of c-src kinase activity. Although it is not clear how the conformational changes take place, it is possible that the dephosphorylation and phosphorylation at the c-src-specific phosphorylation site are related to such conformational changes since the c-src-specific phosphorylation (30, 52) appears to be closely related to the inhibitory regulation of the kinase activity (12; Tanaka et al., in preparation) and since the c-src-specific phosphorylation site Tyr is present within the carboxyterminal c-src-specific region (11, 34) . It is also possible that the ability of a src protein to form a complex with pSO-p90 proteins in CEF is related to such conformational changes since the p90-binding site is thought to be present within the putative regulatory domain (48 (14, 29) , and for the murine c-src protein associated with polyomavirus middle-T antigen (5, 13) . Cell transformation by a src protein thus appears to be accompanied by high in vitro kinase activity as measured by its autophosphorylating ability, although in some cases its manifestation through autophosphorylation differs from that through exogenous substrates (14, 25, 26, 29) .
It has been reported that the c-src protein in neural retina or neurons possesses the high in vitro kinase activity (6, 26, 53) , which appears to be due to the presence of a regulated functional form of the c-src protein and does not cause cell transformation (6) . Interestingly, the v-src protein also does not cause transformation of a certain type of neural cell, PC12 rat phaeochromocytoma cells, but induces cell differentiation from nonneuron cells to neuronlike cells (1) . These results suggest that high src kinase activity alone is not sufficient to account for cell transformation and that target proteins or enzymes regulating the src function also play an important role in cell transformation, as well as in the normal expression of the c-src function.
